Twist Bioscience Reports Fiscal 2018 Fourth Quarter and Full Year Financial Results and Highlights Commercial and Operational Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. USO
6. GOOGL
7. APGE
8. NAVN
9. DFTX
10. IBM

Go back to Twist Bioscience Reports Fiscal 2018 Fourth Quarter and Full Year Financial Results and Highlights Commercial and Operational Progress

Twist Bioscience Corporation (TWST) Reports Q4 Loss of $6.59; Offers FY19 Revenue Guidance

December 19, 2018 4:09 PM EST

Twist Bioscience Corporation (NASDAQ: TWST) reported Q4 EPS of ($6.59), versus ($6.68) reported last year. Revenue for the quarter came in at $8.4 million, versus $3.5 million reported last year.

It has been an exceptional year for Twist Bioscience, with significant top-line growth across all business areas and both operational and... More